These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17436237)

  • 21. Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.
    De Beaudrap P; Etard JF; Diouf A; Ndiaye I; Guèye NF; Guèye PM; Sow PS; Mboup S; Ndoye I; Ecochard R; Eric D;
    Am J Trop Med Hyg; 2009 Jun; 80(6):1047-53. PubMed ID: 19478274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda.
    Kagaayi J; Makumbi F; Nakigozi G; Wawer MJ; Gray RH; Serwadda D; Reynolds SJ
    AIDS; 2007 May; 21(9):1208-10. PubMed ID: 17502733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HIV infection in women].
    Haberl A
    MMW Fortschr Med; 2009 Apr; 151(18):45-6, 48. PubMed ID: 19769075
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-HIV agents. Why are drug holidays dangerous?
    TreatmentUpdate; 2009 Jan; 21(1):6-7. PubMed ID: 19248285
    [No Abstract]   [Full Text] [Related]  

  • 26. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
    Susaengrat W; Mitchai M; Leerattanapetch N
    J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
    Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP;
    J Infect Dis; 2009 Jul; 200(2):206-15. PubMed ID: 19508157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seeking a cure for AIDS.
    Laurence J
    AIDS Read; 2008 May; 18(5):228, 234. PubMed ID: 18589476
    [No Abstract]   [Full Text] [Related]  

  • 30. Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
    Bongiovanni M; Gori A; Lepri AC; Antinori A; de Luca A; Pagano G; Chiodera A; Puoti M; Monforte Ad;
    Clin Infect Dis; 2007 Sep; 45(5):650-3. PubMed ID: 17683003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HIV agents. New evidence changes guidelines about when to start treatment.
    TreatmentUpdate; 2009 Jan; 21(1):2-4. PubMed ID: 19248282
    [No Abstract]   [Full Text] [Related]  

  • 34. Micronutrient deficiencies less common in patients on ART.
    Thaczuk D
    IAPAC Mon; 2006 Dec; 12(12):419-20. PubMed ID: 17405218
    [No Abstract]   [Full Text] [Related]  

  • 35. CD4 cell count distributions and HIV-associated mortality in Africa.
    Lawn SD; Wood R
    J Infect Dis; 2007 Apr; 195(7):1078-9; author reply 1079. PubMed ID: 17330800
    [No Abstract]   [Full Text] [Related]  

  • 36. Malnutrition and infection: complex mechanisms and global impacts.
    Schaible UE; Kaufmann SH
    PLoS Med; 2007 May; 4(5):e115. PubMed ID: 17472433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Number of chronically hungry people is rising by 5m a year.
    Burgermeister J
    BMJ; 2003 Dec; 327(7427):1303. PubMed ID: 14656814
    [No Abstract]   [Full Text] [Related]  

  • 38. First cases of a pestilence more malignant.
    Hendrickse RG
    Ann Trop Paediatr; 2001 Sep; 21(3):189. PubMed ID: 11579855
    [No Abstract]   [Full Text] [Related]  

  • 39. The life of a virus hunter.
    Cowley G
    Newsweek; 2006 May; 147(20):54-6, 58, 60 passim. PubMed ID: 16708554
    [No Abstract]   [Full Text] [Related]  

  • 40. Aid agencies fear for future of pastoralists in Horn of Africa.
    Moszynski P
    BMJ; 2007 Nov; 335(7627):958-9. PubMed ID: 17991959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.